Article
Enhancement of antitumor response of staphylococcal enterotoxin C2 mutant 2M-118 by promoting cell-mediated antitumor immunity.
International immunopharmacology - 10 May 2024
Chen Xinlin, Liu Yuguo, Du Bohai, Shi Mingjie, Lin Zeheng, Li Hongyi, Chen Juyu, Wu Meifen, Shi Ming
Abstract excerpt
BACKGROUND: Staphylococcal enterotoxin C2 (SEC2) is used as an immunotherapeutic drug in China. However, SEC2 are limited due to its immunosuppressive and toxic effects. A SEC2 2M-118 (H118A/T20L/G22E) mutant generated by site-directed mutagenesis was studied to elucidate the underlying antitumor mechanism. METHODS: The effects of 2M-118 on mouse fibrosarcoma (Meth-A) cells and cytokine responses were tested in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
